October 1, 2024

The US Food and Drug Administration (USFDA) has given Zydus Lifesciences permission to produce a generic version of Enzalutamide

During Monday’s trading session on the Bombay Stock Exchange (BSE), Biocon’s shares saw a 2% decline, falling to ₹361.5.

The deputy CEO of the Ayushman Bharat initiative, Dr. Ravi Vimal, was the subject of a corruption probe that

Following the mysterious death of Dr. Kartikeya Srivastava, a 28-year-old Master of Surgery (MS) student at Motilal Nehru Medical

In an effort to enhance healthcare services throughout the state, the Madhya Pradesh government announced on Sunday that it

According to a recent survey conducted by the diagnostics company Healthians, 31% of Indians suffer from excessive cholesterol, with

The cardiology department of the Government Medical College in Thiruvananthapuram successfully completed six unusual cardiac procedures, which was a